AzTrials
AzTrials

Pelvic Organ ProlapseNCT05422209

The Influence of Simultaneous Posterior Colporrhaphy and Perineoplasty on the Efficiency and Safety of Mesh-augmented Sacrospinal Fixation (Apical Sling) in Advanced POP Repair.

A study testing Mesh-augmented sacrospinal fixation with posterior colporrhaphy and perineoplasty. and Mesh-augmented sacrospinal fixation with posterior colporrhaphy. in people with Pelvic Organ Prolapse, run by Saint Petersburg State University, Russia at 1 site in Russia.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This is a prospective randomized controlled study, designed to assess the influence of posterior colporrhaphy and perineoplasty performed simultaneously with mesh-augmented sacrospinal fixation (apical sling) in advanced pelvic organ prolapse repair. Read more about this study

Who is it for?
Ages 45 to 80 years, women only
Conditions the study is for
Pelvic Organ Prolapse
What is being tested?
Mesh-augmented sacrospinal fixation with posterior colporrhaphy and perineoplasty. and Mesh-augmented sacrospinal fixation with posterior colporrhaphy.
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
310 participants
Where
1 siteRussia
Study dates
9 Sep 2022to 9 May 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 45 to 80 years
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • The age of a subject is 45 to 80 years.
  • Leading point of prolapse is at the level of the hymen or distal to the hymen (Ba, C>=0 according to POP-Q classification)
  • Patient's ability to read and sign the informed consent form.
  • Socialized patient who is able to fill in validated questionnaires and arrive for control postoperative examination in future.
  • Patient's consent for participation in the study.

Who cannot join

  • The subject has presence of oncologic disease which was diagnosed earlier or is active now.
  • The subject had prior surgery for POP, SUI or hysterectomy
  • The subject has gynecological deseases (recurrent uterine bleeding, endometrial hyperplasia, the presence of atypical cells in cervical smears, adenomyosis, multiple uterine myoma)
  • The subject has urinary incontinence
  • The subject is planning pregnancy
  • The subject has an active urinary tract infection or skin infection in the region of surgery or acute infectious desease
Show all 10Show fewer
  • The subject is unable to visit postoperative check-ups
  • Refusal from participation.
  • Bp > C according to POP-Q system.
  • gh < 4 cm and > 6 cm according to POP-Q system.

Trial locations and contacts

1 site in 1 country.

Russia1 site
  • Saint-Petersburg State University Hospital

    Saint Petersburg, 190103

Other trials in Russia

About this study

Official title: The Influence of Simultaneous Posterior Colporrhaphy and Perineoplasty on the Efficiency and Safety of Mesh-augmented Sacrospinal Fixation (Apical Sling) in Advanced POP Repair. Randomized Controlled Study.

This is a prospective randomized controlled study, designed to assess the influence of posterior colporrhaphy and perineoplasty performed simultaneously with mesh-augmented sacrospinal fixation (apical sling) in advanced pelvic organ prolapse repair.

Read the detailed description

BACKGROUND Pelvic organ prolapse (POP) is revealed by the gynecological examination in 40-60 % of parous women. A pelvic floor defect is represented by cystocele almost in a half of cases. At the same time it is known that just the loss of apical support favors going out of the anterior vaginal wall beyond the hymen. Today the vast majority of specialists share one view that the uterus with its sacral-uterine-cardinal ligament complex is a key element for the reliable support of the pelvic floor. It is also considered that perineal body insufficiency promotes the development of POP because the small pelvic organs do not have support on which they could lie. The perineal body is a part of the support level III according to DeLancey. Hiatus enlargement is associated with damage of the elevator muscle of anus and one of the factors for POP development both at a clinical examination and ultrasound scanning. Perineoplasty is one of the methods for correction of hiatus opening and anatomical perineal body insufficiency. An important aspect in POP surgery consists in prevention of a recurrence after the surgical treatment. It is important to mention that today there are no randomized studies comparing the efficiency of transvaginal pelvic floor reconstruction using a mesh for apical fixation with and without the recovery of the support level 3 according to DeLancey. Thus, understanding of mechanisms for prevention of repeated surgeries is fundamental and essential for successful treatment of POP.

PREOPERATIVE ASSESSMENT All patients who meet eligibility criteria will undergo a preoperative assessment: medical history, physical and vaginal examination, assessing pelvic organ prolapse according to Pelvic Organ Prolapse Quantification System (POP-Q). All patients will complete questionnaires validated in Russia: Pelvic Floor Disability Index (PFDI-20), Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire, short form (PISQ-SF), Patient Global Impression of Improvement (PGI-I).

MATERIALS AND METHODS Our hypothesis is that posterior colporrhaphy and perineoplasty performed simultaneously with mesh-augmented sacrospinal fixation reduces POP recurrence in any compartment.

Taking into account the available data on frequency of recurrences after unilateral sacrospinal fixation according to hybrid technology (7.4 %) and also clinical observation on frequency of recurrences after three-level hybrid reconstruction (1 %), study power of 80 %, significance level of 5 %, 282 patients are necessary to confirm an expected difference in frequency of recurrences. In order to compensate data losses, the calculated sample size was increased by 10 %. As a result, the total sample size is 310 patients.

All enrolled patients will be randomly assigned to mesh-augmented sacrospinal fixation with posterior colporrhaphy or sacrospinal fixation with posterior colporrhaphy and perineoplasty treatment groups in equal ratio the day before the surgery, using computer randomization.

All data will be collected by medical staff not involved in treatment. Collected pre- and postoperative data will be anonymized using unique codes, that patients will receive immediately after randomization.

All surgical interventions will be performed by 4 qualified surgeons. Postoperative follow-up will be performed 6, 12 and 24 months after surgery by 2 researchers, who will be blinded about the type of intervention.

Being tested
Mesh-augmented sacrospinal fixation with posterior colporrhaphy and perineoplasty., Mesh-augmented sacrospinal fixation with posterior colporrhaphy.
Keywords
pelvic organ prolapse, vaginal repair, vaginal mesh, sacrospinous fixation, colporrhaphy, perineoplasty
Medical subject headings
Pelvic Organ Prolapse

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Mesh-augmented sacrospinal fixation with posterior colporrhaphy and perineoplasty.Procedure or surgery

    Vaginal mesh-augmented sacrospinal fixation with posterior colporrhaphy and perineoplasty.

  • Mesh-augmented sacrospinal fixation with posterior colporrhaphy.Procedure or surgery

    Vaginal mesh-augmented sacrospinal fixation with posterior colporrhaphy.

Study groups in NCT05422209
Study groupRoleWhat they receive
Mesh-augmented sacrospinal fixation with posterior colporrhaphy and perineoplasty.Active comparatorNot described
Receives: Procedure: Mesh-augmented sacrospinal fixation with posterior colporrhaphy and perineoplasty.
Mesh-augmented sacrospinal fixation with posterior colporrhaphy.Active comparatorNot described
Receives: Procedure: Mesh-augmented sacrospinal fixation with posterior colporrhaphy.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Objective cure rate

    The patient is considered cured if there is no prolapse beyond the hymen and the cervix is above -1 cm according to POP-Q (0-1 stage)

    Measured: 24 months (2 years)

Secondary outcomes (4)
  1. Satisfaction with the surgery

    Measured through the Patient Global Impression of Improvement questionnaire (PGI-I), validated in Russia. The patient marks the number that best describes her post-operative condition, compared with how it was before surgery. The score ranges from 1 (very much better) to 7 (very much worse).

    Measured: Measured postoperatively at intervals of 6, 12 and 24 months postoperatively

  2. The impact of treatment on sexual function

    Measured through the scoring of Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12) validated in Russia. The scale evaluates sexual function in patients with urinary incontinence and/or POP. The responses are graded on a five-point Likert scale ranging from 0 (always) to 4 (never). Items 1 - 4 are reversely scored and a total of 48 is the maximum score. The higher scores indicate better sexual function.

    Measured: Measured postoperatively at intervals of 6, 12 and 24 months postoperatively

  3. The impact of treatment on the quality of life

    Measured through the Pelvic Floor Disability Index (PFDI-20), validated in Russia. The item includes 20 questions. The score ranges from 0 to 300. The higher the score, the worse the outcome.

    Measured: Measured postoperatively at intervals of 6, 12 and 24 months postoperatively

  4. Observed complications

    Presence of any adverse effects such as: bleeding requiring blood transfusion, haematoma, organ perforation, nerve injury, vaginal scarring and shortening, wound infection, urinary tract infection, pelvic pain, mesh extrusion in the vagina, mesh erosion into the urinary tract, dyspareunia de novo, de novo urgency, atonic bladder, de novo stress urinary incontinence

    Measured: Measured postoperatively at intervals of 6, 12 and 24 months postoperatively

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Jun 2022
  2. Study start9 Sep 2022
  3. Primary completion9 Mar 2024
  4. Study completion9 May 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
310 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05422209
Sponsor's protocol ID
SSF and perineoplasty
Status last verified
Jul 2024
First submitted
18 May 2022
Last updated
3 Jul 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Shakhaliev RA, Shulgin AS, Kubin ND, Kondratiev AS, Suchkov DA, Neklasova SV, Shkarupa DD. The influence of simultaneous posterior colporrhaphy and perineoplasty on the efficiency and safety of mesh-augmented sacrospinal fixation (apical sling) in advanced POP repair. Trials. 2024 Oct 2;25(1):647. doi: 10.1186/s13063-024-08448-4.

    PubMed 39358750

Questions about this trial

What is this clinical trial studying?

A study testing Mesh-augmented sacrospinal fixation with posterior colporrhaphy and perineoplasty. and Mesh-augmented sacrospinal fixation with posterior colporrhaphy. in people with Pelvic Organ Prolapse, run by Saint Petersburg State University, Russia at 1 site in Russia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 3 Jul 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Russia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Objective cure rate (time frame: 24 months (2 years)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05422209, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Jul 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in